COTSOGLOU, CHRISTIAN

COTSOGLOU, CHRISTIAN  

DIPARTIMENTO DI SCIENZE CLINICHE "LUIGI SACCO" (attivo dal 01/01/2002 al 27/04/2012)  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA) 1-giu-2016 V.M. MazzaferroN. PersoneniDROZ DIT BUSSET, MICHELEC. Cotsoglou + Article (author) -
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients 1-gen-2017 C. SpositoD. CitterioM. BonginiC. CotsoglouV. Mazzaferro + Article (author) -
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. 1-gen-2019 V. MazzaferroM. Droz dit BussetC. CotsoglouN. PersoneniF. de Braud + Article (author) -
Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma 1-ott-2008 P. LamperticoM. ViganòS. BhooriM. BonginiM. IavaroneC. CotsoglouA. RussoG. RossiM. ColomboV. Mazzaferro + Article (author) -
Liver resection and transplantation for metastases from gastroenteropancreatic neuroendocrine tumors 1-gen-2020 M. VirdisC. CotsoglouJ. CoppaR. RossiV. Mazzaferro + Book Part (author) -
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms 1-ott-2019 Pusceddu, SaraCotsoglou, ChristianMazzaferro, Vincenzode Braud, FilippoPruneri, Giancarlo + Article (author) -
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 1-lug-2015 F. PietrantonioV. MazzaferroCOTSOGLOU, CHRISTIANG. FanettiP. BiondaniC. MaggiF. de Braud + Article (author) -
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 1-mar-2019 F. PietrantonioC. CotsoglouG. FucàF. NichettiJ. CoppaA. AlessiM. PrisciandaroM. Droz-Dit BussetS. CoralloA. MennittoG. RandonA. RaimondiB. PadovanoF. PerroneM. Di BartolomeoF. de BraudV. Mazzaferro + Article (author) -
Perioperative triplet chemotherapy and cetuximab in patients with RAS wild type high recurrence risk or borderline resectable colorectal cancer liver metastases 6-set-2017 F. PietrantonioC. CotsoglouA. MennittoF. de BraudV. Mazzaferro + Article (author) -
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study 1-nov-2019 V. MazzaferroM. VirdisC. SpositoC. CotsoglouM. Droz Dit BussetM. BonginiJ. Coppa + Article (author) -
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 1-set-2017 Pietrantonio, FilippoCotsoglou, ChristianInfante, GabrieleCoppa, JorgelinaPadovano, BarbaraMennitto, AlessiaNiger, MonicaFucà, GiovanniLazzati, SilviaGreco, GiorgioDelconte, GabrieleDe Braud, FilippoMazzaferro, VincenzoDi Bartolomeo, Maria + Article (author) -
Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases? 1-set-2018 C. CotsoglouV. Mazzaferro + Article (author) -